Medifast
MED
#9228
Rank
A$0.16 B
Marketcap
A$15.14
Share price
0.37%
Change (1 day)
-24.84%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2025 (TTM): -A$8.68 Million

According to Medifast's latest financial reports the company's current earnings are A$0.42 Billion. In 2024 the company made an earning of A$3.99 Million a decrease over its 2023 earnings that were of A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$8.68 Million-317.22%
2024 A$3.99 M-97.72%
2023 A$0.17 B-31.61%
2022 A$0.25 B-14.56%
2021 A$0.30 B61.25%
2020 A$0.18 B47.36%
2019 A$0.12 B31.82%
2018 A$95.81 M74.26%
2017 A$54.98 M47.56%
2016 A$37.26 M-6.36%
2015 A$39.79 M-16.28%
2014 A$47.53 M2%
2013 A$46.59 M44.4%
2012 A$32.27 M-16.75%
2011 A$38.76 M-12.14%
2010 A$44.12 M63.85%
2009 A$26.92 M136.71%
2008 A$11.37 M35.74%
2007 A$8.38 M-142.56%
2006 -A$19.7 Million-448.43%
2005 A$5.65 M35.62%
2004 A$4.16 M-16.51%
2003 A$4.99 M
2000 A$0.67 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion 2,697.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
A$0.11 B-1,550.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-A$15.31 Million 93.60%๐Ÿ‡บ๐Ÿ‡ธ USA